{
  "cik": 1671858,
  "cik_padded": "0001671858",
  "entityName": "ARS Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-097478",
      "filed": "2026-03-09",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 339000.0,
        "cash": 41317000.0,
        "eps_diluted": -1.74,
        "free_cash_flow": -171205000.0,
        "net_income": -171298000.0,
        "operating_cash_flow": -170866000.0,
        "operating_income": -179448000.0,
        "revenue": 84278000.0,
        "stockholders_equity": 114258000.0,
        "total_assets": 327652000.0,
        "total_liabilities": 213394000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.8676504052232668,
        "revenue_growth_yoy": -0.054638863027067046,
        "roa_avg2y": -0.5047045911565177,
        "roa_period_end": -0.5228046830173477,
        "roe_avg2y": -0.9232999870639472,
        "roe_period_end": -1.4992210611073185
      }
    },
    {
      "accn": "0001193125-26-097478",
      "filed": "2026-03-09",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 563000.0,
        "cash": 50817000.0,
        "eps_diluted": 0.08,
        "free_cash_flow": 12985000.0,
        "net_income": 7998000.0,
        "operating_cash_flow": 13548000.0,
        "operating_income": -3083000.0,
        "revenue": 89149000.0,
        "stockholders_equity": 256798000.0,
        "total_assets": 351153000.0,
        "total_liabilities": 94355000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.36742887405665153,
        "net_margin": 0.08971497156445948,
        "operating_margin": -0.034582552804854796,
        "revenue_growth_yoy": 2970.633333333333,
        "roa_avg2y": 0.027374426918528736,
        "roa_period_end": 0.022776396613442006,
        "roe_avg2y": 0.03280840433343315,
        "roe_period_end": 0.031145102376186732
      }
    },
    {
      "accn": "0001193125-26-097478",
      "filed": "2026-03-09",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 175000.0,
        "cash": 70971000.0,
        "eps_diluted": -0.57,
        "free_cash_flow": -59441000.0,
        "net_income": -54365000.0,
        "operating_cash_flow": -59266000.0,
        "operating_income": -67520000.0,
        "revenue": 30000.0,
        "stockholders_equity": 230760000.0,
        "total_assets": 233188000.0,
        "total_liabilities": 2428000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.010521754203501474,
        "revenue_growth_yoy": -0.9772036474164134,
        "roa_avg2y": -0.21128087940103726,
        "roa_period_end": -0.23313806885431496,
        "roe_avg2y": -0.21588576103056512,
        "roe_period_end": -0.23559109031027908
      }
    },
    {
      "accn": "0000950170-25-042320",
      "filed": "2025-03-20",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 199000.0,
        "cash": 210518000.0,
        "eps_diluted": -0.87,
        "free_cash_flow": -40277000.0,
        "net_income": -34682000.0,
        "operating_cash_flow": -40078000.0,
        "operating_income": -35516000.0,
        "revenue": 1316000.0,
        "stockholders_equity": 272886000.0,
        "total_assets": 281435000.0,
        "total_liabilities": 8549000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.03132810037891281,
        "revenue_growth_yoy": -0.7609880130766437,
        "roa_avg2y": -0.2022975901260204,
        "roa_period_end": -0.12323271803435962,
        "roe_avg2y": -0.28708244866876087,
        "roe_period_end": -0.1270933649949063
      }
    },
    {
      "accn": "0000950170-24-034689",
      "filed": "2024-03-21",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 55000.0,
        "cash": 60063000.0,
        "eps_diluted": -0.7,
        "free_cash_flow": -17616000.0,
        "net_income": -20243000.0,
        "operating_cash_flow": -17561000.0,
        "operating_income": -19454000.0,
        "revenue": 5506000.0,
        "stockholders_equity": -31269000.0,
        "total_assets": 61446000.0,
        "total_liabilities": 16676000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.08873643835616439,
        "roa_period_end": -0.32944373921817527,
        "roe_avg2y": 0.8933165640652236
      }
    },
    {
      "accn": "0000950170-23-009491",
      "filed": "2023-03-23",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 917000.0,
        "cash": 386569000.0,
        "free_cash_flow": -32113000.0,
        "net_income": -32947000.0,
        "operating_cash_flow": -31196000.0,
        "operating_income": -32918000.0,
        "stockholders_equity": -14052000.0,
        "total_assets": 394804000.0,
        "total_liabilities": 11927000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.08345153544543622,
        "roe_avg2y": 0.9047769432506282
      }
    },
    {
      "accn": "0000950170-22-005202",
      "filed": "2022-03-31",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -58777000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-097478",
    "filed": "2026-03-09",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001671858.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001671858.json"
  },
  "ticker": "SPRY"
}